Metformin inhibits estrogen‐dependent endometrial cancer cell growth by activating the AMPK–FOXO1 signal pathway

Metformin is an oral biguanide commonly used for treating type II diabetes and has recently been reported to possess antiproliferative properties that can be exploited for the prevention and treatment of a variety of cancers. The mechanisms underlying this effect have not been fully elucidated. Our...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Jingfang, Hong, Liangli, Luo, Chaohuan, Li, Zhi, Zhu, Yuzhang, Huang, Tianliang, Zhang, Yongneng, Yuan, Huier, Hu, Yaqiu, Wen, Tengfei, Zhuang, Wanling, Cai, Bozhi, Zhang, Xin, Huang, Jiexiong, Cheng, Jidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198961/
https://www.ncbi.nlm.nih.gov/pubmed/27636742
http://dx.doi.org/10.1111/cas.13083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198961/
https://www.ncbi.nlm.nih.gov/pubmed/27636742
http://dx.doi.org/10.1111/cas.13083

Ejemplares similares